Polyubiquitin-C and calmodulin-like protein 5 have the potential to replace SPT as a noninvasive allergy diagnosis in children and are promising candidates as biomarkers for identifying newborns predisposed to develop AD. Here, UBC is linked to Alzheimer disease.